SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $7,487,547 | -33.2% | 65,382 | -19.7% | 0.27% | +5.0% |
Q1 2023 | $11,217,019 | +0.7% | 81,383 | -5.3% | 0.26% | +35.9% |
Q4 2022 | $11,138,049 | +1.3% | 85,955 | -13.6% | 0.19% | +2.7% |
Q3 2022 | $10,996,000 | +171.4% | 99,477 | +91.8% | 0.19% | +136.7% |
Q1 2022 | $4,051,000 | -8.2% | 51,860 | +5.8% | 0.08% | -31.9% |
Q4 2021 | $4,413,000 | +7.7% | 49,009 | +10.6% | 0.12% | +54.7% |
Q3 2021 | $4,098,000 | +62.7% | 44,309 | +31.1% | 0.08% | +74.4% |
Q1 2021 | $2,519,000 | – | 33,800 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |